These results align with prior studies that have described the role of TPr in the migration of endothelial cells and endothelial barrier function, and suggest that in addition to platelet-specific functions, ifetroban exerts some of its antimetastatic efficacy by modulating endothelial cells in the tumor microenvironment [30, 41]. The gene discussed is TPR; the disease is neoplasm.